| pubmed-article:12777670 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C0040034 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C0253563 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:12777670 | lifeskim:mentions | umls-concept:C1373125 | lld:lifeskim |
| pubmed-article:12777670 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12777670 | pubmed:dateCreated | 2003-6-2 | lld:pubmed |
| pubmed-article:12777670 | pubmed:abstractText | Platelet glycoprotein IIb/IIIa inhibitors have significantly reduced the incidence of 30-day ischemic events during percutaneous coronary interventions (PCI). However, each of the three currently available agents has different pharmacological characteristics, safety, efficacy and costs. There has not been a direct comparison between eptifibatide and abciximab in the rates of major adverse cardiac events, major complications and thrombocytopenia. | lld:pubmed |
| pubmed-article:12777670 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12777670 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12777670 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12777670 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12777670 | pubmed:issn | 1042-3931 | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:GrubergLuisL | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:BeyarRafaelR | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:GrenadierEhud... | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:MarkiewiczWal... | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:AronsonDoronD | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:HalabiMajdiM | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:SuleimanMahmo... | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:HammermanHaim... | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:GoldbergAlexa... | lld:pubmed |
| pubmed-article:12777670 | pubmed:author | pubmed-author:BoulusMonther... | lld:pubmed |
| pubmed-article:12777670 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12777670 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:12777670 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12777670 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12777670 | pubmed:pagination | 319-23 | lld:pubmed |
| pubmed-article:12777670 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:meshHeading | pubmed-meshheading:12777670... | lld:pubmed |
| pubmed-article:12777670 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12777670 | pubmed:articleTitle | Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention. | lld:pubmed |
| pubmed-article:12777670 | pubmed:affiliation | Division of Invasive Cardiology, Department of Cardiology, Rambam Medical Center, Haifa-31096, Israel. gruberg67@hotmail.com | lld:pubmed |
| pubmed-article:12777670 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12777670 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12777670 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12777670 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12777670 | lld:pubmed |
